COMP <GO>
PLRX vs HYPD // GROSS PROFIT MARGIN
Pliant Therapeutics Inc. (NASDAQ) VS. Hyperion DeFi Inc. (NASDAQ) • 15-METRIC TALLY: PLRX 0
— HYPD 3
■ METRIC PARITY
LAST: $0.86 (-0.13%) • MKT CAP: $53.3M
gross-margins
—
LAST: $3.22 (-8.13%) • MKT CAP: $54.1M
gross-margins
62.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLRX VS. HYPD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PLRX | HYPD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 62.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 180.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | HYPD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.3 | 49.4 | -14.06 | HYPD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $53.3M | $54.1M | -$873.1K | HYPD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PLRX REV | HYPD REV | PLRX GROSS % | HYPD GROSS % | PLRX FCF | HYPD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $813.5K | — | 62.7% | -$128.7M | -$14.8M |
| FY 2024 | $0 | $57.3K | — | -50.0% | -$159.4M | -$30.3M |
| FY 2023 | $1.6M | $3.8K | — | — | -$116.4M | -$23.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLRX // BETA —
HYPD // BETA —